It is a pharma public limited company based in Thane, Maharashtra, India, established in 2003.
2003 | Thane, Maharashtra, India | ActiveGlo-Vision Medicaments Limited, a active public limited company, was established on 06 June 2003 in Thane, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2003PLC140778. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.65 M.
It upholds a active non-compliant status. Its leadership includes Dinesh Parasmal Raka (Director), Parasmal Uttamchand Raka (Additional Director), Manoj Parasmal Raka (Additional Director). Past directors included Kanakmal Uttamchand Raka, Yogita Manoj Raka, Ratilal Uttamchand Raka. It holds ₹10.37 Cr open charges and ₹2.50 M settled loans. Its latest AGM occurred on 26 September 2017, with the balance sheet filed on 31 March 2017. It is based at Building No.3, Godown Bo.117, 1St Floor, Arihant Commercial Complex, Purna Villag, E, Bhiwand, Thane, Maharashtra, 421302.
U24230MH2003PLC140778
140778
06 June 2003
₹3.00 M
₹1.65 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Glo-Vision Medicaments Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Parasmal Raka | Director | 06 Jun 2003 | Current |
| Parasmal Uttamchand Raka | Additional Director | 06 Jul 2010 | Current |
| Manoj Parasmal Raka | Additional Director | 31 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2009 | Past |
| Pramod Abcsdd | Director | 31 Mar 2014 | Past |
| Pramod Abcsdd | Director | 06 Jul 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glo-Vision Medicaments Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 99.69% decrease. The company also saw a substantial improvement in profitability, with a 29.83% increase in profit. The company's net worth dipped by a decrease of 0.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Glo-Vision Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹103,670,000.00
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Oct 2012 | Bank Of Baroda | ₹4.50 Cr | Open |
| 09 May 2012 | Bank Of Baroda | ₹1.17 M | Open |
| 27 Jul 2011 | Bank Of Baroda | ₹4.50 Cr | Open |
| 09 Dec 2010 | Idbi Bank Limited | ₹1.25 Cr | Open |
| 15 Jan 2005 | The Ajantha Urban Co-Op; Bank Ltd. | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Glo-Vision Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glo-Vision Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glo-Vision Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Glo-Vision Medicaments Limited last Annual general meeting of members was held on 26 Sep 2017 as per latest MCA records. was completed.
Glo-Vision Medicaments Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was recorded as a recent event.
A charge with Bank Of Baroda amounted to Rs. 45.00 M with Charge ID 10380696 was registered on 05 Oct 2012. was recorded as a recent event.
A charge with Bank Of Baroda of Rs. 45.00 M registered on 27 Jul 2011 with Charge ID 10305404 was modified on 05 Oct 2012. was recorded as a recent event.
A charge with Bank Of Baroda amounted to Rs. 1.17 M with Charge ID 10359219 was registered on 09 May 2012. was recorded as a recent event.
The activity A charge with Bank Of Baroda amounted to Rs. 45.00 M with Charge ID 10305404 was registered on 27 Jul 2011. was completed.
The CIN of Glo-Vision Medicaments Limited is U24230MH2003PLC140778.
Glo-Vision Medicaments Limited is headquartered at Building No.3, Godown Bo.117, 1St Floor, Arihant Commercial Complex, Purna Villag, E, Bhiwand, Thane, Maharashtra, 421302.
Glo-Vision Medicaments Limited was incorporated on 06 June 2003.
The current directors of Glo-Vision Medicaments Limited are
The primary industry of Glo-Vision Medicaments Limited is Pharma.
Glo-Vision Medicaments Limited is unlisted.
The authorized capital of Glo-Vision Medicaments Limited is ₹3.00 M, and the paid-up capital is ₹1.65 M.
The compliance status of Glo-Vision Medicaments Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX